JP Morgan Chase’s Aspen Aerogels ASPN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPN
KL
OCMI
NIM
GKFF
JP Morgan Chase's ASPN Position: Q2 2026 in Review
JP Morgan Chase increased its Aspen Aerogels (ASPN) stake by 4% in Q2 2026, buying an estimated $191K and bringing the position to 1,004,383 shares worth $6.01M. The position accounts for ﹤0.01% of the portfolio, ranked #3287.
JP Morgan Chase first reported a position in ASPN in Q4 2017 and has held it in 28 quarters since. The position peaked at $9.39M in Q3 2025. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.
- JP Morgan Chase held 1,004,383 shares of Aspen Aerogels worth $6.01M as of Q2 2026.
- JP Morgan Chase bought 38,891 Aspen Aerogels shares in Q2 2026, an estimated $191K.
- Aspen Aerogels made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3287 holding.
- JP Morgan Chase first reported a position in Aspen Aerogels in Q4 2017 and has held it in 28 quarters since.
- JP Morgan Chase's Aspen Aerogels position peaked at $9.39M in Q3 2025.
- 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.